SEC Form 4 · accession 0001203311-17-000016
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Srinivas Akkaraju
Director
Period of report
May 19, 2017
Accepted (ET)
May 23, 2017 · 7:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 19, 2017 | A | 3,700 | $0.00 | A | 28,505 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F3 | $66.60 | May 19, 2017 | A | 9,260 | A | — | May 18, 2027 | Common Stock | 9,260 | 9,260 | D |
Explanation of responses
- F1These shares represent restricted stock units and will be settled in common stock upon vesting.
- F2Restricted stock units shall vest in full on May 18, 2018.
- F3The option shall vest in full on May 18, 2018.